Share this post on:

Product Name :
Azilsartan

Search keywords :
Azilsartan

drugId :
null

Target Vo:
Angiotensin II Receptor Type 1

Target Vo Short Name :
AT1

Moa_Name:
Angiotensin II Receptor Type 1 antagonists

First Approval Country :
Japan

First Approval Date Filter:
2012

Origin Company_Name :
Takeda Pharmaceutical Co Ltd

Active Company_Name :
Hebei Renhe Yikang Pharmaceutical Co Ltd

Active Indication_Name:
Hypertension

In Active Indication_Name:
Diabetes Mellitus, Type 2

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
PTEN Rabbit mAb Autophagy
STAT1 alpha Rabbit mAb Formula
RAB8A Antibody: RAB8A Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 24 kDa, targeting to RAB8A. It can be used for WB assays with tag free, in the background of Human.

Share this post on:

Author: Betaine hydrochloride